Patents/Assignees

LENTIGEN TECHNOLOGY, Inc.

12 patents in portfolio

US12465641utility2025
Chimeric Antigen Receptor Therapies for Treating Solid Tumors
0 cites
US12391740utility2025
Compositions and Methods for Treating Cancer with Anti-bcma Immunotherapy
0 cites
US12371490utility2025
Compositions and Methods for Treating Cancer with Anti-cd19/cd22 Immunotherapy
0 cites
US12365718utility2025
Compositions and Methods for Treating Cancer with Duocars
0 cites
US12193995utility2025
Method to Treat Cancer with Engineered T-cells
0 cites
US12122831utility2024
Compositions and Methods for Treating Cancer with Anti-cd19/cd22 Immunotherapy
0 cites
US12024554utility2024
Compositions and Methods for Treating HIV/AIDS with Immunotherapy
0 cites
US11969443utility2024
Compositions and Methods for Treating Cancer with Self-driving Chimeric Antigen Receptors
0 cites
US11905515utility2024
Chimeric Antigen Receptors and Methods of Use
0 cites
US11802142utility2023
Compositions and Methods for Treating Cancer with Duocars
0 cites
US11680103utility2023
Compositions and Methods for Treating Cancer with Anti-cd19/cd20 Immunotherapy
0 cites
US11590169utility2023
Compositions and Methods for Treating Cancer with Anti-cd123 Immunotherapy
0 cites